Latest Apartments News

Tusker Minerals has outlined a multi-billion-tonne JORC Exploration Target at its Douala Basin Project in Cameroon, highlighting a globally significant rutile-rich mineral sands system with strong infrastructure advantages.

Ryman Healthcare reported steady retirement living sales in Q1 FY27 with a 7% rise in net resales, buoyed by serviced apartments. The company remains on track for FY27 build targets and sees robust aged care occupancy despite housing market headwinds.

Fletcher Building has raised its FY26 EBIT guidance to $400m-$403m, buoyed by stronger volumes across key divisions and a $52m boost from property sales. However, caution remains over potential project delays and cost inflation impacting early FY27 performance.

AusQuest’s maiden drilling at Playa Kali in Peru has delivered encouraging copper and molybdenum assays, validating the prospectivity of a large iron-oxide copper-gold system and setting the stage for targeted follow-up exploration.

West Cobar Metals (ASX: WC1) has identified promising high-grade scandium drill targets at its Salazar project, alongside metallurgical testwork indicating potential for lower-cost scandium production via atmospheric leaching and bioleaching.

Prospect Resources has completed key diamond and aircore drilling at its Mumbezhi Copper Project, uncovering new copper mineralisation zones and progressing a Scoping Study on schedule.

Swift TV has landed a second multi-site hospitality contract, expanding its footprint in premium Western Australian accommodation and reinforcing its recurring revenue model.

Summerset Group maintained stable new sales in Q2 2026 with a notable 26% jump in resales, while prudently reducing its New Zealand build rate in response to economic uncertainty.

Barkly Rare Earths (ASX:BAK) is launching a substantial 10,000-metre drilling campaign targeting expansion of its 40 million tonne inferred rare earth resource at the Barkly Project, with drilling set to start imminently.

Southern Cross Gold's latest drilling at Sunday Creek reveals strong antimony dominance alongside gold, with standout intercepts reinforcing the project's critical mineral potential.

Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.

Koba Resources’ recent IP survey at the Stannex Prospect reveals robust chargeability anomalies aligned with high-grade tin mineralisation, setting the stage for an imminent 3,000m drilling campaign.